DOUG BUERGER, is a scientific consultant with experience leading teams in all phases of pharmaceutical and medical device lifecycle development including research, development, manufacturing, business development, quality, clinical, and regulatory. Currently, Mr. Buerger works as a pharmaceutical consultant at Shinkei Therapeutics, coordinating contract development and manufacturing and clinical research services pursuing agency approval and commercialization of CNS therapeutics. He served as a manager for product development at Hercon Pharmaceuticals, LLC, where he was in charge of coordination of development pipeline, foster innovation mentality and problem solving skills development in scientific staff personnel, developed and maintained annual departmental budgets. Mr. Buerger received his bachelor’s Bachelor of Science (cum laude) from University of Utah in 1981 and completed his Doctor of Philosophy in materials science & engineering at University of Utah in 1987.
Jianguang Qian has over 15 years of financial management experience in manufacturing, engineering, internet and internet plus enterprises. He has served in listed companies and large group companies. He isproficient in finance, taxation, financing and financial information management. He has large-scale financial department management experience and cross-functional team management experience. He worked as the head of finance at Minmetalscondo Co, Ltd, an affiliated company of Minmetals Land (HKG: 0230), from April 2013 to July 2014. From June 2018 to June 2020, he was a financial director of the Shared Accounting Center of Lv Ma Ma, a listed company on the National Equities Exchange and Quotations in China. He was responsible for Lv Ma Ma ’s accounting and taxation, and had a team of 70 subordinates; he was also in charge of supervising the proposed listing of Lv Ma Ma in Hong Kong, as well as investor relations. He was also responsible for the establishment of and IT transformation of the business finance system of Lv Ma Ma. In addition, Jianguang Qian served as the Chief Financial Officer during the working period of Merit-link. He was in charge of the business process reengineering of Merit-link, the innovation and financial empowerment of the industrial internet business, and took the lead in the financing and listing of Merit-link during his tenure as the Chief Financial Officer of Youland Group from November 2014 to June 2018. Jianguang Qian’s responsibilities included has financial management, financial and operational analysis and internal audit responsibilities of the Youland Group Jianguang Qian graduated from the Department of Finance, Lanzhou University of Technology, China in 2006, and obtained a master's degree in accounting from Shanghai University of Finance and Economics, China in 2012. He is a certified member of the Association of Chartered Certified Accountants of ACCA, a CMA American Management Certified Public Accountant and a Chinese Intermediate Accountant.
Appointment of Director and Chairman
December 8, 2021| Form type | Form description | Filing date |
|---|
All shareholders of the Company may request, free of charge, a hard copy of the Company's complete audited financial statements filed with the SEC. To request a hard copy of the Company's audited financial statements, please contact the Investor Relations Department of the Company, whose contact information is as follows: ir@nft-limited.com